RINF (CXXC5) is overexpressed in solid tumors and is an unfavorable prognostic factor in breast cancer†

MGMT expression levels predict disease stabilisation, progression-free and overall survival in patients with advanced melanomas treated with DTIC

(2010) Christian Busch et al.   EUROPEAN JOURNAL OF CANCER

A Novel Wilms Tumor 1 (WT1) Target Gene Negatively Regulates the WNT Signaling Pathway

(2010) Myoung Shin Kim et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Molecular basis for therapy resistance

(2010) Per E. Lønning   Molecular Oncology

Identification of β-catenin binding regions in colon cancer cells using ChIP-Seq

(2010) Daniel Bottomly et al.   NUCLEIC ACIDS RESEARCH

Functional involvement of RINF, retinoid-inducible nuclear factor (CXXC5), in normal and tumoral human myelopoiesis

(2009) F. Pendino et al.   BLOOD

Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial

(2009) Kathy S Albain et al.   LANCET ONCOLOGY

Structure of the MLL CXXC domain–DNA complex and its functional role in MLL-AF9 leukemia

(2009) Tomasz Cierpicki et al.   NATURE STRUCTURAL & MOLECULAR BIOLOGY

The CXXC finger 5 protein is required for DNA damage-induced p53 activation

(2009) Min Zhang et al.   Science in China. Series C, Life sciences / Chinese Academy of Sciences

CXXC Domain of Human DNMT1 Is Essential for Enzymatic Activity

(2008) Mihika Pradhan et al.   BIOCHEMISTRY

Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen

(2008) Sherene Loi et al.   BMC GENOMICS

Epithelial Progeny of Estrogen-Exposed Breast Progenitor Cells Display a Cancer-like Methylome

(2008) A. S.L. Cheng et al.   CANCER RESEARCH

CXXC5 Is a Novel BMP4-regulated Modulator of Wnt Signaling in Neural Stem Cells

(2008) Therese Andersson et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Alterations of the CxxC domain preclude oncogenic activation of mixed-lineage leukemia 2

(2008) C Bach et al.   ONCOGENE